Loading...
OTCMKNBWY
Market cap10bUSD
Dec 24, Last price  
13.14USD
1D
0.23%
1Q
-13.04%
Jan 2017
-19.34%
Name

Kirin Holdings Co Ltd

Chart & Performance

D1W1MN
OTCM:KNBWY chart
P/E
14.84
P/S
0.78
EPS
139.16
Div Yield, %
540.36%
Shrs. gr., 5y
-1.97%
Rev. gr., 5y
2.03%
Revenues
2.13t
+7.28%
1,205,092,991,5831,634,757,326,5701,263,625,000,0001,400,608,000,0001,922,877,000,0002,278,473,000,0002,177,802,000,0002,071,774,000,0002,186,177,000,0002,254,585,000,0002,195,795,000,0002,196,925,000,0002,075,070,000,0001,863,730,000,0001,930,522,000,0001,941,305,000,0001,849,545,000,0001,821,570,000,0001,989,468,000,0002,134,393,000,000
Net income
112.70b
+1.52%
48,343,321,55451,377,749,95053,512,000,00066,713,000,00080,182,000,00049,172,000,00011,394,000,0007,407,000,00056,198,000,00085,656,000,00032,392,000,000-47,329,000,000118,158,000,000242,057,000,000164,202,000,00081,438,000,00099,841,000,00059,790,000,000111,007,000,000112,697,000,000
CFO
203.21b
+49.90%
118,046,438,831125,994,052,015123,685,000,000114,585,000,000131,281,000,000189,907,000,000218,025,000,000196,792,000,000212,061,000,000205,517,000,000155,247,000,000171,011,000,000226,468,000,000221,710,000,000198,051,000,000178,826,000,000164,839,000,000219,303,000,000135,562,000,000203,206,000,000
Dividend
Jun 25, 20240.24397 USD/sh
Earnings
Feb 12, 2025

Profile

Kirin Holdings Company, Limited produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products in Japan and internationally. It operates through four segments: Japan Beer and Spirits Businesses, Japan Non-Alcoholic Beverages Business, Oceania Integrated Beverages Business, and Pharmaceuticals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, and sake and other food products; as well as manufacture and supply of Four Roses bourbon; and acts as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.
URL
https://www.kirinholdings.co.jp/
IPO date
May 16, 1949
Employees
30,538
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,134,393,000
7.28%
1,989,468,000
9.22%
1,821,570,000
-1.51%
Cost of revenue
1,933,184,000
2,105,086,000
1,962,979,000
Unusual Expense (Income)
NOPBT
201,209,000
(115,618,000)
(141,409,000)
NOPBT Margin
9.43%
Operating Taxes
46,611,000
47,615,000
31,193,000
Tax Rate
23.17%
NOPAT
154,598,000
(163,233,000)
(172,602,000)
Net income
112,697,000
1.52%
111,007,000
85.66%
59,790,000
-40.11%
Dividends
(57,500,000)
(53,778,000)
(54,184,000)
Dividend yield
3.44%
3.25%
3.52%
Proceeds from repurchase of equity
(35,000)
(50,051,000)
(36,012,000)
BB yield
0.00%
3.03%
2.34%
Debt
Debt current
120,080,000
114,459,000
101,502,000
Long-term debt
670,275,000
471,478,000
520,597,000
Deferred revenue
212,114,000
Other long-term liabilities
119,070,000
234,139,000
52,300,000
Net debt
173,946,000
32,733,000
(44,187,000)
Cash flow
Cash from operating activities
203,206,000
135,562,000
219,303,000
CAPEX
(113,810,000)
(98,479,000)
(86,335,000)
Cash from investing activities
(226,091,000)
(10,399,000)
(56,408,000)
Cash from financing activities
35,909,000
(167,835,000)
(180,463,000)
FCF
120,222,000
(290,594,000)
(147,828,000)
Balance
Cash
140,343,000
96,436,000
157,398,000
Long term investments
476,066,000
456,768,000
508,888,000
Excess cash
509,689,350
453,730,600
575,207,500
Stockholders' equity
1,656,362,000
1,479,473,000
1,354,034,000
Invested Capital
1,768,298,650
1,552,121,400
1,366,506,500
ROIC
9.31%
ROCE
8.68%
EV
Common stock shares outstanding
809,853
821,755
833,599
Price
2,066.00
2.73%
2,011.00
8.88%
1,847.00
-24.12%
Market cap
1,673,156,298
1.25%
1,652,549,305
7.33%
1,539,657,353
-24.76%
EV
2,140,359,298
1,958,463,305
1,778,628,353
EBITDA
288,436,000
(29,681,000)
(60,279,000)
EV/EBITDA
7.42
Interest
6,579,000
6,478,000
7,044,000
Interest/NOPBT
3.27%